Sulthiame reduced breathing interruptions in sleep apnea patients, pointing toward a viable drug treatment. A European clinical trial has found that the drug sulthiame can reduce breathing pauses and improve sleep quality in people with obstructive sleep apnea, with researchers from the Universit